L-Arginine preferentially dilates stenotic segments of coronary arteries thereby increasing coronary flow

Journal of Internal Medicine

Volumn 264, Issue 3, 2008, Pages 237-244

  Lauer, T ^a   Kleinbongard, P ^a   Rath, J ^b   Schulz, R ^c   Kelm, M ^a   Rassaf, T ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Department of Cardiology and Internal Medicine   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

ACE inhibition; Arginase; Coronary artery disease; L arginine; Nitric oxide

Indexed keywords

ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; ISOSORBIDE DINITRATE; LOW DENSITY LIPOPROTEIN; RADICAL;

ADULT; ANALYSIS OF VARIANCE; ANGIOCARDIOGRAPHY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DOPPLER FLOWMETRY; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARGININE; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY VESSELS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOSORBIDE DINITRATE; LIPIDS; MALE; MIDDLE AGED; VASODILATION; VASODILATOR AGENTS;

EID: 49349090283     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01943.x     Document Type: Article

References (32)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 340: 115 26.
2. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res 1994 31: 131 43.
3. Ming X-F, Barandier C, Viswambharan H et al. Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 2004 110: 3708 14.
4. Ryoo S, Lemmon CA, Soucy KG et al. Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res 2006 99: 951 60.
5. Jurewicz M, McDermott DH, Sechler JM et al. Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 2007 18: 1093 102.
6. Bachetti T, Comini L, Francolini G et al. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 2004 37: 515 23.
7. Wang B-Y, Ho H-KV, Lin PS et al. Regression of atherosclerosis. Role of nitric oxide and apoptosis. Circulation 1999 99: 1236 41.
8. Lauer T, Kleinbongard P, Preik M et al. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature. Basic Res Cardiol 2003 98: 84 9.
9. Lauer T, Preik M, Rassaf T et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA 2001 98: 12814 9.
10. Kelm M, Rath J. Endothelial dysfunction in human coronary circulation: relevance of the l-arginine-NO pathway. Basic Res Cardiol 2001 96: 107 27.
11. Bode-Böger SM, Böger RH, Alfke H et al. l-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. Circulation 1996 93 : 85 90.
12. Tousoulis D, Davies GJ, Tentolouris C et al. Vasomotor effects of l- and d-arginine in stenotic atheromatous coronary plaque. Heart 2001 86 : 296 301.
13. Doutreleau S, Mettauer B, Piquard F et al. Chronic l-arginine supplementation enhances endurance exercise tolerance in heart failure patients. Int J Sports Med 2006 27 : 567 72.
14. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 : 1206 52.
15. Cleeman JI. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel 3). JAMA 2001 285 : 2486 97.
16. Doucette JW, Corl PD, Payne HM et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992 85 : 1899 911.
17. Reiber JHC, Serruys PW, Kooijmann CJ et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985 71 : 280 8.
18. Rackley CE, Dodge HT, Coble YD Jr. et al. A method for determining left ventricular mass in man. Circulation 1964 29 : 666 71.
19. Tousoulis D, Davies G, Tentolouris C et al. Coronary stenosis dilatation induced by l-arginine. Lancet 1997 349 : 1812 3.
20. Quyyumi AA. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. J Am Coll Cardiol 1998 32 : 904 11.
21. Oemar BS, Tschudi MR, Godoy N et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998 97 : 2494 8.
22. Brandes RP, Kim D-Y, Schmitz-Winnenthal F-H et al. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice. Role of soluble guanylyl cyclase. Hypertension 2000 35 :231 6.
23. Tousoulis D, Tentolouris C, Crake T et al. Complex stenosis morphology and vasomotor responses to inhibition of nitric oxide synthesis. Heart 2000 84 :529 34.
24. Zhang C, Hein TW, Wang W et al. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004 44 :935 43.
25. Romero MJ, Platt DH, Tawfik HE et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008 102 :95 102.
26. Smith AR, Hagen TM. Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid. Biochem Soc Trans 2003 31 :1447 9.
27. Quyyumi AA, Dakak N, Diodati JG et al. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol 1997 30 :1220 7.
28. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991 81 :695 700.
29. Kleinbongard P, Schulz R, Rassaf T et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006 107 :2943 51.
30. Dandona P, Dhindsa S, Ghanim H et al. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens 2007 21 :20 7.
31. Mancini GBJ, Henry GC, Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996 94 :258 65.
32. Creager MA, Gallagher SJ, Girerd XJ et al. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992 90 :1248 53.